1053 related articles for article (PubMed ID: 19695354)
1. Oral antiplatelet therapy in unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous coronary intervention: is it time for a guideline update?
Saucedo JF
Am J Cardiol; 2009 Sep; 104(5 Suppl):4C-8C. PubMed ID: 19695354
[TBL] [Abstract][Full Text] [Related]
2. Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE): updated standing orders for ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction.
Cannon CP
Crit Pathw Cardiol; 2010 Jun; 9(2):55-81. PubMed ID: 20520214
[TBL] [Abstract][Full Text] [Related]
3. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
Manoukian SV
Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355
[TBL] [Abstract][Full Text] [Related]
4. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.
Antman EM
Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302
[TBL] [Abstract][Full Text] [Related]
6. Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) ST-segment elevation myocardial infarction critical pathway toolkit.
Cannon CP;
Crit Pathw Cardiol; 2008 Dec; 7(4):223-31. PubMed ID: 19050418
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative.
Bottorff MB; Nutescu EA; Spinler S
Pharmacotherapy; 2007 Aug; 27(8):1145-62. PubMed ID: 17655514
[TBL] [Abstract][Full Text] [Related]
8. [Mexican Cardiology Society Guidelines on the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. Cancún, Quintana Roo 15-16 November 2002. Cooperative Group of Consensus].
Lupi-Herrera E;
Arch Cardiol Mex; 2002; 72 Suppl 2():S5-44. PubMed ID: 12661524
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy in percutaneous coronary intervention: integration of prasugrel into clinical practice.
Thomas D; Giugliano RP
Crit Pathw Cardiol; 2009 Mar; 8(1):12-9. PubMed ID: 19258833
[TBL] [Abstract][Full Text] [Related]
10. [Antiplatelet therapy in acute coronary syndromes without ST segment elevation].
Umman B
Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():13-9. PubMed ID: 16613770
[TBL] [Abstract][Full Text] [Related]
11. High-risk non-ST-segment elevation myocardial infarction versus ST-segment elevation myocardial infarction: same behaviour and outcome?
Manari A; Albiero R; De Servi S
J Cardiovasc Med (Hagerstown); 2009 Oct; 10 Suppl 1():S13-6. PubMed ID: 19851215
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy in early management of non-ST-segment elevation acute coronary syndrome: the 2002 and 2007 guidelines from North America and Europe.
Thomas D; Giugliano RP
J Cardiovasc Pharmacol; 2008 May; 51(5):425-33. PubMed ID: 18418272
[TBL] [Abstract][Full Text] [Related]
13. Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
Willis P; Voeltz MD
Am J Cardiol; 2009 Sep; 104(5 Suppl):34C-8C. PubMed ID: 19695359
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
Spinler SA
Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
[TBL] [Abstract][Full Text] [Related]
15. Reperfusion strategies in acute ST-segment elevation myocardial infarction.
Boden WE; Gupta V
Curr Opin Cardiol; 2008 Nov; 23(6):613-9. PubMed ID: 18830078
[TBL] [Abstract][Full Text] [Related]
16. The medical management of acute coronary syndromes and potential roles for new antithrombotic agents.
Pollack CV; Goldberg AD
J Emerg Med; 2008 May; 34(4):417-28. PubMed ID: 18226874
[TBL] [Abstract][Full Text] [Related]
17. Challenges in oral antiplatelet therapy: ST-segment elevation myocardial infarction.
Dauerman HL
Am J Cardiol; 2009 Sep; 104(5 Suppl):39C-43C. PubMed ID: 19695360
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic, antithrombin, and antiplatelet treatment of acute coronary syndromes.
Puma JA; Sketch MH
J Am Osteopath Assoc; 2000 Nov; 100(11 Suppl):S8-12. PubMed ID: 11191119
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of prasugrel compared with clopidogrel in patients with acute coronary syndromes: results of TRITON-TIMI 38 trials.
Mariani M; Mariani G; De Servi S
Expert Rev Cardiovasc Ther; 2009 Jan; 7(1):17-23. PubMed ID: 19105763
[TBL] [Abstract][Full Text] [Related]
20. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
